Angelini Pharma S.p.A.

Overview

Angelini Pharma S.p.A. is a leading Italian pharmaceutical company focused on the research, development, and commercialization of treatments for central nervous system disorders, pain, and rare diseases. It operates as a part of the privately-held Angelini Group.

Therapeutic areas

API / Drug Master Files

Angelini Pharma S.p.A. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TRAZODONE HCLActive1978-06-14

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Angelini Pharma S.p.A. in our records. PharmaTek screens the full directory against live FDA enforcement data.